Product
Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine
1 clinical trial
1 indication
Indication
Meningococcal ImmunisationClinical trial
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix® or NeisVac-C® in Healthy Toddlers 12 to 23 Months of AgeStatus: Completed, Estimated PCD: 2020-10-14